genome analysis
Lucid Genomics Raises €1.3M in Pre-Seed Funding Round
The Berlin-based startup holds an exclusive license to genome analysis software from the Max Planck Society and Charité.
GeneDx Q2 Revenues Grow 45 Percent Driven by Exome, Genome Tests
The company saw a 52 percent year-over-year increase in whole-exome and whole-genome testing volume during Q2, booking $50.7 million in revenues for this business segment.
Clinicians have put together a software program that scans databases for new information and applies it to thousands of patient genomes on a monthly basis.
Broken String Biosciences, Crick Institute Team up for ALS Research
The partnership is being conducted through the Crick Institute's business engagement fund, a new initiative supported by the UK's Medical Research Council.
GeneDx Lays off 10 Percent of Staff as Part of $40M Cost Cutting Plan, Secures $75M Debt Financing
The clinical genetic testing company also lowered its revenue guidance for 2023 and reported $53.3 million in revenues for the third quarter.